Dec 17 2019 FDA blasts Alkermes for underselling the risks of VivitrolBy Leonard BuschelDecember 17, 20190 Lowers tolerance, raises profits – DECEMBER 11, 2019 – “Vivitrol is being promoted in a way that does not adequately…
